Cyclacel Pharmaceuticals Inc pfd conv ex 6% shares owned by UBS Group
Quarter-by-quarter ownership of Cyclacel Pharmaceuticals Inc pfd conv ex 6% (CYCCP) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Cyclacel Pharmaceuticals Inc pfd conv ex 6%
Tip: Access up to 7 years of quarterly data
All positions including Cyclacel Pharmaceuticals Inc pfd conv ex 6% held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cyclacel Pharmaceuticals Inc pfd conv ex 6% by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $276 | 17 | 16.29 |
| 2023-06-30 | $66 | 6 | 11.00 |
| 2023-03-31 | $320 | 23 | 13.96 |
| 2022-09-30 | $4.0k | 548 | 7.30 |
| 2022-06-30 | $4.0k | 503 | 7.95 |
| 2022-03-31 | $4.0k | 629 | 6.36 |
| 2021-12-31 | $4.0k | 677 | 5.91 |
| 2020-03-31 | $23k | 3.9k | 5.91 |
| 2019-12-31 | $20k | 4.1k | 4.92 |
| 2019-09-30 | $20k | 4.4k | 4.52 |
| 2019-06-30 | $11k | 2.2k | 4.94 |
| 2019-03-31 | $11k | 2.4k | 4.55 |
| 2018-12-31 | $12k | 2.3k | 5.18 |
| 2018-09-30 | $11k | 2.2k | 5.08 |
| 2018-06-30 | $15k | 2.2k | 6.93 |
| 2018-03-31 | $13k | 2.2k | 6.01 |
| 2017-12-31 | $4.0k | 570 | 7.02 |
| 2017-09-30 | $2.0k | 270 | 7.41 |
| 2017-03-31 | $4.0k | 609 | 6.57 |
| 2016-12-31 | $12k | 2.0k | 6.11 |
| 2016-09-30 | $5.0k | 686 | 7.29 |
| 2016-06-30 | $9.0k | 1.5k | 6.19 |
| 2016-03-31 | $3.0k | 594 | 5.05 |
| 2015-12-31 | $999 | 162 | 6.17 |
| 2015-09-30 | $999 | 163 | 6.13 |
| 2015-03-31 | $999 | 165 | 6.06 |
Top funds holding Cyclacel Pharmaceuticals Inc pfd conv ex 6%
View all funds holding Cyclacel Pharmaceuticals Inc pfd conv ex 6%